Ceretas Limited (ASX:CTS)
1.055
-0.025 (-2.31%)
Last updated: Sep 7, 2026, 2:10 PM AEST
Ceretas Market Cap
Ceretas has a market cap or net worth of 77.09 million as of September 4, 2026.
Market Cap
77.09M
Enterprise Value
75.90M
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.06
ChartMarket Cap Chart
Since July 23, 2026, Ceretas's market cap has increased from 41.40M to 77.09M, an increase of 86.21%. That is a compound annual growth rate of 19,480.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 77.09M | 2.37% |
| Sep 3, 2026 | 75.30M | 5.50% |
| Sep 2, 2026 | 71.38M | -4.76% |
| Sep 1, 2026 | 74.94M | 6.06% |
| Aug 31, 2026 | 70.66M | 10.00% |
| Aug 28, 2026 | 64.24M | 12.50% |
| Aug 27, 2026 | 57.10M | - |
| Aug 26, 2026 | 57.10M | - |
| Aug 25, 2026 | 57.10M | -4.19% |
| Aug 24, 2026 | 59.60M | 1.83% |
| Aug 21, 2026 | 58.53M | 8.61% |
| Aug 20, 2026 | 53.89M | -0.66% |
| Aug 19, 2026 | 54.25M | 2.70% |
| Aug 18, 2026 | 52.82M | 5.71% |
| Aug 17, 2026 | 49.96M | - |
| Aug 14, 2026 | 49.96M | 2.19% |
| Aug 13, 2026 | 48.89M | 10.48% |
| Aug 12, 2026 | 44.25M | 5.08% |
| Aug 11, 2026 | 42.11M | - |
| Aug 10, 2026 | 42.11M | 3.51% |
| Aug 7, 2026 | 40.68M | - |
| Aug 6, 2026 | 40.68M | - |
| Aug 5, 2026 | 40.68M | -0.87% |
| Aug 4, 2026 | 41.04M | 2.68% |
| Aug 3, 2026 | 39.97M | 1.82% |
| Jul 31, 2026 | 39.26M | 0.92% |
| Jul 30, 2026 | 38.90M | -6.03% |
| Jul 29, 2026 | 41.40M | -3.33% |
| Jul 28, 2026 | 42.83M | 2.56% |
| Jul 27, 2026 | 41.75M | 14.71% |
| Jul 24, 2026 | 36.40M | -12.07% |
| Jul 23, 2026 | 41.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 83.57B |
| Sigma Healthcare | 31.06B |
| Pro Medicus | 18.17B |
| Ramsay Health Care | 12.04B |
| Avecho Biotechnology | 81.14M |
| SomnoMed | 75.82M |
| Arovella Therapeutics | 73.74M |
| Prescient Therapeutics | 71.50M |